Junyent Felix, Kremer Eric J
Institut de Génétique Moléculaire de Montpellier, Montpellier, France; Université de Montpellier, Montpellier, France.
Institut de Génétique Moléculaire de Montpellier, Montpellier, France; Université de Montpellier, Montpellier, France.
Curr Opin Pharmacol. 2015 Oct;24:86-93. doi: 10.1016/j.coph.2015.08.004. Epub 2015 Aug 25.
Canine adenovirus type 2 (CAV-2) vectors are powerful tools for fundamental and applied neurobiology due to their negligible immunogenicity, preferential transduction of neurons, widespread distribution via axonal transport, and duration of expression in the mammalian brain. CAV-2 vectors are internalized in neurons by the selective use of coxsackievirus and adenovirus receptor (CAR), which is located at the presynapse in neurons. Neuronal internalization and axonal transport is mediated by CAR, which potentiates vector biodistribution. The above characteristics, together with the ∼30kb cloning capacity of helper-dependent (HD) CAV-2 vectors, optimized CAV-2 vector creation, production and purification, is expanding the therapeutic and fundamental options for CNS gene transfer.
犬2型腺病毒(CAV-2)载体因其免疫原性可忽略不计、对神经元的优先转导、通过轴突运输的广泛分布以及在哺乳动物大脑中的表达持续时间,成为基础和应用神经生物学的强大工具。CAV-2载体通过选择性利用位于神经元突触前的柯萨奇病毒和腺病毒受体(CAR)被神经元内化。神经元内化和轴突运输由CAR介导,这增强了载体的生物分布。上述特性,连同辅助依赖型(HD)CAV-2载体约30kb的克隆能力、优化的CAV-2载体构建、生产和纯化,正在扩大中枢神经系统基因转移的治疗和基础选择。